Camouflaged nanoparticles used to deliver killer protein to cancer

A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers. Using a protein toxin called gelonin from a plant found in the Himalayan mountains, the researchers caged the proteins in self-assembled metal-organic framework (MOF) nanoparticles to protect them from the body’s immune system. To enhance the longevity of the drug in the bloodstream and to selectively target the tumor, the team cloaked the MOF in a coating made from cells from the tumor itself.

Read more in this Penn State News article.

June 14, 2018 Penn State Health News

If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.